ReviewEndocrinology, diabetes & metabolism2026
Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era.
Zakariye Isak Mohamed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.